Detalhe da pesquisa
1.
Comparison of Visual Methods to Reanalyze Provocative Test Data from Randomized Controlled Clinical Trials in New- or Recent-Onset Type 1 Diabetes.
S D Med
; 76(suppl 6): s23-s24, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37732925
2.
A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia.
Nat Genet
; 38(7): 794-800, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16767104
3.
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes.
Sci Transl Med
; 16(746): eadn2404, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38718135
4.
Pediatric Endocrine Society Statement on Considerations for Use of Teplizumab (Tzield™) in Clinical Practice.
Horm Res Paediatr
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38663372
5.
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review.
Commun Med (Lond)
; 4(1): 66, 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38582818
6.
Type 1 Diabetes Prevention: a systematic review of studies testing disease-modifying therapies and features linked to treatment response.
medRxiv
; 2023 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131690
7.
Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review.
Commun Med (Lond)
; 3(1): 130, 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794169
8.
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.
Diabetes Technol Ther
; 25(1): 1-12, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36472543
9.
Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling.
Hum Mol Genet
; 19(8): 1387-98, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20080939
10.
Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective.
Diabetes
; 71(4): 610-623, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316839
11.
IL-6 receptor blockade does not slow ß cell loss in new-onset type 1 diabetes.
JCI Insight
; 6(21)2021 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34747368
12.
Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors.
Cancer Res
; 64(24): 8811-5, 2004 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15604237
13.
Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with cushing disease.
J Clin Endocrinol Metab
; 90(9): 5134-40, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15941871
14.
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.
J Clin Invest
; 125(8): 3285-96, 2015 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26193635
15.
Safety of medications and hormones used in pediatric endocrinology: adrenal.
Pediatr Endocrinol Rev
; 2 Suppl 1: 134-45, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16456492
16.
Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial.
Lancet Diabetes Endocrinol
; 2(9): 710-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24997559
17.
Elimination of Pasteurella pneumotropica from a mouse barrier facility by using a modified enrofloxacin treatment regimen.
J Am Assoc Lab Anim Sci
; 53(5): 517-22, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25255075
18.
Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study.
Lancet Neurol
; 13(8): 777-87, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24997880
19.
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial.
Lancet Diabetes Endocrinol
; 1(4): 284-94, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24622414
20.
The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.
J Clin Endocrinol Metab
; 94(7): 2406-13, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19383776